In this study, the contribution of type I interferons (IFNs) to protection against infection with enterovirus 71 (EV71) was investigated using a murine model where the virus was administrated to neonatal Institute of Cancer Research (ICR) mice by either the intraperitoneal (i.p.) or the oral route. In i.p. inoculated mice, post-infection treatment of dexamethasone (5 mg kg−1 at 2 or 3 days after infection) exacerbated clinical symptoms and increased the tissue viral titre. In contrast, polyriboinosinic : polyribocytidylic acid [poly(I : C); 10 or 100 μg per mouse at 12 h before infection], a potent IFN inducer, improved the survival rate and decreased the tissue viral titres after EV71 challenge, which correlated with an increase in serum IFN-α concentration, the percentage of dendritic cells, their expression of major histocompatibility complex class II molecule and IFN-α in spleen. Treatment with a neutralizing antibody for type I IFNs (104 neutralizing units per mouse, 6 h before and 12 h after infection) resulted in frequent deaths and higher tissue viral load in infected mice compared with control mice. In contrast, an early administration of recombinant mouse IFN-αA (104 U per mouse for 3 days starting at 0, 1 or 3 days after infection) protected the mice against EV71 infection. In vitro analysis of virus-induced death in three human cell lines showed that human type I IFNs exerted a direct protective effect on EV71. It was concluded that type I IFNs play an important role in controlling EV71 infection and replication.
ChangL.-Y.,
LinT.-Y.,
HsuK.-H.8 other authors1999; Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354:1682–1686[CrossRef]
ChangL.-Y.,
HsiaS.-H.,
WuC.-T.,
HuangY.-C.,
LinK.-L.,
FangT.-Y.,
LinT.-Y.2004; Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002. Pediatr Infect Dis J 23:327–332[CrossRef]
GuggenheimM. A.,
BaronS.1977; Clinical studies of an interferon inducer, polyriboinosinic-polyribocytidylic acid [poly(I)-poly(C)], in children. J Infect Dis 136:50–58[CrossRef]
HoM.,
ChenE.-R.,
HsuK.-H.,
TwuS.-J.,
ChenK.-T.,
TsaiS.-F.,
WangJ.-R.,
ShihS.-R.1999; An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 341:929–935[CrossRef]
HsiungG. D.1994; Virus assay, neutralization test and antiviral assay. In Hsiung's Diagnostic Virology pp 46–55 Edited by
HsiungG. D.,
FongC. K. Y.,
LandryM. L.
New Haven: Yale University Press;
HuangC.-C.,
LiuC.-C.,
ChangY.-C.,
ChenC.-Y.,
WangS.-T.,
YehT.-F.1999; Neurologic complications in children with enterovirus 71 infection. N Engl J Med 341:936–942[CrossRef]
KunzmannV.,
KretzschmarE.,
HerrmannT.,
WilhelmM.2004; Polyinosinic-polycytidylic acid-mediated stimulation of human γδ T cells via CD11c dendritic cell-derived type I interferons. Immunology 112:369–377[CrossRef]
LinT.-Y.,
ChangL.-Y.,
HuangY.-C.,
HsuK.-H.,
ChiuC.-H.,
YangK.-D.2002b; Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr 91:632–635[CrossRef]
McMinnP. C.2002; An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26:91–107[CrossRef]
NolanM. A.,
CraigM. E.,
LahraM. M.,
RawlinsonW. D.,
PragerP. C.,
WilliamsG. D.,
ByeA. M.,
AndrewsP. I.2003; Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology 60:1651–1656[CrossRef]
PoastJ.,
SeidelH. M.,
HendricksM. D.,
HaslamJ. A.,
LevyH. B.,
BaronS.2002; Poly I: CLC induction of the interferon system in mice: an initial study of four detection methods. J Interferon Cytokine Res 22:1035–1040[CrossRef]
PyoS.,
GangemiJ. D.,
GhaffarA.,
MayerE. P.1993; Poly I: C-induced antiviral and cytotoxic activities are mediated by different mechanisms. Int J Immunopharmacol 15:477–486[CrossRef]
SasakiO.,
KarakiT.,
ImanishiJ.1986; Protective effect of interferon on infections with hand, foot, and mouth disease virus in newborn mice. J Infect Dis 153:498–502[CrossRef]
SchmidtK. N.,
LeungB.,
KwongM.,
ZaremberK. A.,
SatyalS.,
NavasT. A.,
WangF.,
GodowskiP. J.2004; APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol 172:138–143[CrossRef]
WangS.-M.,
LiuC.-C.,
TsengH.-W.,
WangJ.-R.,
HuangC.-C.,
ChenY.-J.,
YangY.-J.,
LinS.-J.,
YehT.-F.1999; Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis 29:184–190[CrossRef]
YanJ.-J.,
WangJ.-R.,
LiuC.-C.,
YangH.-B.,
SuI.-J.2000; An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J Clin Virol 17:13–22[CrossRef]
YanJ.-J.,
SuI.-J.,
ChenP.-F.,
LiuC.-C.,
YuC.-K.,
WangJ.-R.2001; Complete genome analysis of enterovirus 71 isolated from an outbreak in Taiwan and rapid identification of enterovirus 71 and coxsackievirus A16 by RT-PCR. J Med Virol 65:331–339[CrossRef]
YangK.-D.,
YangM.-Y.,
LiC.-C.,
LinS.-F.,
ChongM.-C.,
WangC.-L.,
ChenR.-F.,
LinT.-Y.2001; Altered cellular but not humoral reactions in children with complicated enterovirus 71 infections in Taiwan. J Infect Dis 183:850–856[CrossRef]